110 related articles for article (PubMed ID: 7561888)
21. Prevalence between different alpha subunits performing the benzodiazepine binding sites in native heterologous GABA(A) receptors containing the alpha2 subunit.
del Río JC; Araujo F; Ramos B; Ruano D; Vitorica J
J Neurochem; 2001 Oct; 79(1):183-91. PubMed ID: 11595770
[TBL] [Abstract][Full Text] [Related]
22. Visualization of alpha5 subunit of GABAA/benzodiazepine receptor by 11C Ro15-4513 using positron emission tomography.
Maeda J; Suhara T; Kawabe K; Okauchi T; Obayashi S; Hojo J; Suzuki K
Synapse; 2003 Mar; 47(3):200-8. PubMed ID: 12494402
[TBL] [Abstract][Full Text] [Related]
23. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
[TBL] [Abstract][Full Text] [Related]
24. Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation.
Leppä E; Linden AM; Rabe H; Vekovischeva OY; Wulff P; Lüddens H; Wisden W; Korpi ER
Eur J Pharmacol; 2011 Sep; 666(1-3):111-21. PubMed ID: 21616065
[TBL] [Abstract][Full Text] [Related]
25. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy.
Macdonald GA; Frey KA; Agranoff BW; Minoshima S; Koeppe RA; Kuhl DE; Shulkin BL; Lucey MR
Hepatology; 1997 Aug; 26(2):277-82. PubMed ID: 9252134
[TBL] [Abstract][Full Text] [Related]
26. Different sensitivities to competitive inhibition of benzodiazepine receptor binding of 11C-iomazenil and 11C-flumazenil in rhesus monkey brain.
Inoue O; Hosoi R; Kobayashi K; Itoh T; Gee A; Suzuki K
Ann Nucl Med; 2001 Apr; 15(2):137-9. PubMed ID: 11448072
[TBL] [Abstract][Full Text] [Related]
27. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties.
Araujo F; Ruano D; Vitorica J
J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469
[TBL] [Abstract][Full Text] [Related]
28. The Search for a Subtype-Selective PET Imaging Agent for the GABA
Lin SF; Bois F; Holden D; Nabulsi N; Pracitto R; Gao H; Kapinos M; Teng JK; Shirali A; Ropchan J; Carson RE; Elmore CS; Vasdev N; Huang Y
Mol Imaging; 2017; 16():1536012117731258. PubMed ID: 28929924
[TBL] [Abstract][Full Text] [Related]
29. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
30. The plasma-occupancy relationship of the novel GABAA receptor benzodiazepine site ligand, alpha5IA, is similar in rats and primates.
Atack JR; Eng WS; Gibson RE; Ryan C; Francis B; Sohal B; Dawson GR; Hargreaves RJ; Burns HD
Br J Pharmacol; 2009 Jul; 157(5):796-803. PubMed ID: 19422390
[TBL] [Abstract][Full Text] [Related]
31. Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor.
Casula MA; Bromidge FA; Pillai GV; Wingrove PB; Martin K; Maubach K; Seabrook GR; Whiting PJ; Hadingham KL
J Neurochem; 2001 Apr; 77(2):445-51. PubMed ID: 11299307
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of ammonia on the benzodiazepine modulatory site on the GABA-A receptor complex of human brain.
Ahboucha S; Araqi F; Layrargues GP; Butterworth RF
Neurochem Int; 2005 Jul; 47(1-2):58-63. PubMed ID: 15913842
[TBL] [Abstract][Full Text] [Related]
33. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
[TBL] [Abstract][Full Text] [Related]
34. The effects of zolpidem treatment on GABA(A) receptors in cultured cerebellar granule cells: changes in functional coupling.
Vlainić J; Švob Štrac D; Jazvinšćak Jembrek M; Vlainić T; Peričić D
Life Sci; 2012 Jun; 90(23-24):889-94. PubMed ID: 22564411
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images.
Myers JF; Rosso L; Watson BJ; Wilson SJ; Kalk NJ; Clementi N; Brooks DJ; Nutt DJ; Turkheimer FE; Lingford-Hughes AR
J Cereb Blood Flow Metab; 2012 Apr; 32(4):731-44. PubMed ID: 22214903
[TBL] [Abstract][Full Text] [Related]
36. Aging-associated changes in the pharmacological properties of the benzodiazepine (omega) receptor isotypes in the rat hippocampus.
Ruano D; Benavides J; Machado A; Vitorica J
J Neurochem; 1995 Feb; 64(2):867-73. PubMed ID: 7830081
[TBL] [Abstract][Full Text] [Related]
37. Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for alpha 1 versus alpha 2 and alpha 3 subunit-containing GABAA receptors.
Atack JR; Smith AJ; Emms F; McKernan RM
Neuropsychopharmacology; 1999 Mar; 20(3):255-62. PubMed ID: 10063485
[TBL] [Abstract][Full Text] [Related]
38. Differential pharmacological properties of GABAA/benzodiazepine receptor complex in dorsal compared to ventral rat hippocampus.
Sarantis K; Sotiriou E; Papatheodoropoulos C; Matsokis N; Angelatou F
Neurochem Int; 2008 May; 52(6):1019-29. PubMed ID: 18069090
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
Sanna E; Busonero F; Talani G; Carta M; Massa F; Peis M; Maciocco E; Biggio G
Eur J Pharmacol; 2002 Sep; 451(2):103-10. PubMed ID: 12231378
[TBL] [Abstract][Full Text] [Related]
40. The hypnotics triazolam and zolpidem have identical metabolic effects throughout the brain: implications for benzodiazepine receptor subtypes.
Piercey MF; Hoffmann WE; Cooper M
Brain Res; 1991 Jul; 554(1-2):244-52. PubMed ID: 1657289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
